United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jun 12, 2026 · Filed Jun 15, 2026

On Jun 12, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$541.39 for US$5.14M under a trading plan, leaving 40,513 shares. Filed Jun 15, 2026 (Form 4).

Sold
9,500 shares
Price
US$541.39 average (US$537.40 to US$545.71)
Value
US$5.14M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 12, 2026Common StockOption exercise9,500US$146.0350,013Direct
Jun 12, 2026Common StockSale399US$537.4049,614Direct
Jun 12, 2026Common StockSale401US$538.4349,213Direct
Jun 12, 2026Common StockSale535US$539.2448,678Direct
Jun 12, 2026Common StockSale3,154US$540.4645,524Direct
Jun 12, 2026Common StockSale1,671US$541.2343,853Direct
Jun 12, 2026Common StockSale1,797US$542.4042,056Direct
Jun 12, 2026Common StockSale240US$543.0341,816Direct
Jun 12, 2026Common StockSale560US$544.4541,256Direct
Jun 12, 2026Common StockSale743US$545.7140,513Direct

Source

View original at SEC

Related